Advanced diagnostics. One compact platform.

EHBT-50 Minilab Multi-Functional Analyser

The EHBT-50 Minilab combines haematology, biochemistry and immunoassay testing in one compact analyser for professional use.

Testing on one platform

The analyser offers touchscreen operation and connectivity options for professional testing workflows.

At a Glance
The EHBT-50 Minilab is a multi-functional diagnostic analyser integrating haematology, biochemistry, and immunoassay testing within one compact platform for professional healthcare settings.

  • Specialism: Integrated point-of-care diagnostics
  • Core Capabilities: Haematology, biochemistry, and immunoassay testing
  • Haematology Parameters: Complete blood count (CBC) and cell morphology analysis
  • Sample Types: Capillary and venous whole blood (assay-dependent)
  • Display & Connectivity: 10.1-inch touchscreen; USB, LAN, and Wi-Fi
  • Physical Footprint: 400 × 350 × 450 mm (L × W × H); ~15 kg
  • Intended Users: Healthcare professionals, pathology networks, and diagnostic service providers
  • Manufacturer: Hunan Ehome Health Technology
  • Exclusive UK Supplier & Distributor: BHR Biosynex (Trade supply, volume quotes, and technical support)

Why choose the EHBT-50?

  • Three disciplines, one analyser: haematology, biochemistry and immunoassay testing.
  • Haematology: complete blood count (CBC) and cell morphology analysis.
  • Assay options: contact BHR Biosynex for the current UK test menu.
  • Compact footprint: approximately 400 × 350 × 450 mm (L × W × H).
  • Throughput depends on the assay and operating workflow. Contact BHR Biosynex for details.
  • UK support: product information, training and technical support from BHR Biosynex.

Haematology and cell morphology

The EHBT-50 supports CBC testing and cell morphology analysis. Refer to the manufacturer’s instructions for reportable parameters, instrument flags and any requirements for manual review.

Test menu
Contact BHR Biosynex for the current UK test menu. Refer to the applicable instructions for use for each assay.
Haematology
Complete blood count (CBC) and cell morphology analysis.
Immunoassay
Contact BHR Biosynex for currently available immunoassays in the UK.
Biochemistry
Contact BHR Biosynex for currently available biochemistry assays in the UK. Please contact BHR Biosynex for updates on assay availability.
Supporting healthcare services
Speak to BHR Biosynex about the analyser, the available assays and whether they suit your service. Refer to the manufacturer’s instructions for the intended use and performance of each assay.
Haval Ozgun - General Manager, Division of Rapid Diagnostics NHS South West London Pathology
Expert perspective:

Haval Ozgun

Bringing advanced diagnostics closer to patients

“The future of healthcare is not just about delivering faster results—it’s about bringing high-quality diagnostics closer
to the patient.”

Haval Ozgun
General Manager, Division of Rapid Diagnostics,
South West London Pathology

In his assessment of the EHBT-50 platform, Haval highlights the potential value of combining haematology, biochemistry and immunoassays in one system. His perspective centres on supporting timely, informed clinical decisions and helping services consider how advanced diagnostic testing can be delivered closer to the point of care. These are potential service benefits, not guaranteed clinical outcomes.

Full Article here:
Beyond Faster Results: Bringing Advanced Diagnostics Closer to the Patient

“…This is truly a game-changing innovation—both for the NHS and, most importantly, for the patients it serves.”

Haval Ozgun General Manager, Division of Rapid Diagnostics NHS South West London Pathology

Transforming diagnostics. Supporting better patient care.

“The future of healthcare is not just about delivering faster results — it's about bringing high-quality diagnostics closer to the patient...”

Three diagnostic disciplines. One portable platform.

“...The Ehome EHBT-50 MiniLab represents a significant step forward by combining haematology, biochemistry, and immunoassays into a single portable platform...”

Faster insights. Better-informed clinical decisions.

“...This innovation has the potential to transform point-of-care testing by enabling clinicians to make faster, more informed decisions, improving patient outcomes...”

Expanding access. Supporting laboratory capacity.

“... reducing pressure on central laboratories, and expanding access to advanced diagnostics wherever care is delivered...”

Transforming diagnostics. Advancing patient care.

“...This is truly a game-changing innovation—both for the NHS and, most importantly, for the patients it serves.” Haval Ozgun General Manager, Division of Rapid Diagnostics NHS South West London Pathology

Ready to rethink point-of-care diagnostics?

Let’s have a conversation! Speak to your BHR Biosynex Account Manager or Call 02476 377210 Email info@bhr.co.uk
Request A Quote

Technical specifications at a glance

Core disciplines Haematology, biochemistry, immunoassay
CBC principle Cell morphology
Sample type Capillary or venous whole blood (assay-dependent)
Sample volume Refer to the assay instructions for sample volume and loading requirements.
Throughput Depends on the assay and operating workflow.
Display 10.1-inch touchscreen
Dimensions 400 × 350 × 450 mm (L × W × H)
Weight Approximately 15 kg, excluding packaging
Connectivity USB, LAN, Wi-Fi and additional connectivity ports
Quality control Refer to the manufacturer’s instructions for instrument and assay QC requirements.
Power supply 100–240 V, 50/60 Hz
Experts Insights

Beyond Faster Results: Bringing Advanced Diagnostics Closer to the Patient 

The future of point-of-care testing (POCT) is about more than delivering faster results. As healthcare moves towards more flexible, community-based services, advances in diagnostic technology are making sophisticated testing increasingly accessible closer to the patient. Featuring insights from Haval Ozgun of NHS South West London Pathology and Hadjer Bouchair of BHR Biosynex, this article explores how innovations such as the Ehome EHBT-50 MiniLab, which combines haematology, biochemistry and immunoassays in one compact platform, could transform diagnostic pathways, support more informed clinical decisions and complement central laboratory services. Discover how next-generation POCT could help shape a more connected, efficient and patient-centred approach to healthcare.

Why BHR Biosynex?

BHR Biosynex is the exclusive UK distributor of the EHBT-50 Minilab. Our team can discuss the available UK test menu, technical requirements, demonstrations, training and implementation support to help you assess whether the analyser meets your service needs. 

Call 02476 377210 or email info@bhr.co.uk.

Request A Quote

Explore what integrated diagnostic testing could mean for your service. Speak to BHR Biosynex about the EHBT-50 Minilab, its currently available UK assays and your workflow requirements.

For professional use only. Read the manufacturer’s instructions for use. Assay availability, regulatory status, performance and suitability must be verified for the intended clinical application.

Frequently asked questions 

Contact BHR Biosynex to confirm UK availability of the HbA1c assay.

Refer to the manufacturer’s instructions for the CBC parameters and differential reported by the analyser.

Please contact BHR Biosynex for the current UK test menu and assay availability.

Contact BHR Biosynex using the enquiry form, email info@bhr.co.uk or call 02476 377210.